SOURCE: Solos Endoscopy, Inc.

February 08, 2007 08:31 ET

Solos Endoscopy, Inc. Receives Orders for Breast Endoscopy System and Anticipates Increasing Demand

BOSTON, MA -- (MARKET WIRE) -- February 8, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce that the Company has received orders for the Solos Breast Endoscopy System. The Company recently launched their new Solos Breast Endoscopy System and has received positive feedback from doctors throughout the country. Solos Endoscopy has received numerous requests and shipped several systems to hospitals around the U.S. for product evaluation.

The Solos Breast Endoscopy System is ideal for performing ductoscopy procedures, which allows physicians to examine the mammary ducts under direct visualization and consequently, allow for earlier detection of disease than other procedures, including mammography. The Company will be posting information on the new endoscopy system on their website at

The Solos Breast Endoscopy System employs advanced microendoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of breast cancers arise. The system is a versatile and customizable piece of medical equipment that can support multiple procedures including biopsies, lumpectomies, and other intraductal procedures. The Solos Breast Endoscopy System has the potential to help in the early diagnosis of more than 1 million cases of breast cancer discovered each year throughout the world.

"We are very pleased with the overwhelming response we have received regarding our Solos Breast Endoscopy System. Considering that we just began the marketing campaign two weeks ago, this is an amazing testimonial to the demand for this type of product in the medical market," stated Dee Fletcher, Director of Clinical Services for Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit and download your FREE copy of Big Apple ComPro.

Contact Information

  • Contact:
    Investor Relations for Solos Endoscopy, Inc.